Brief Communication abstract


Nature Cell Biology 4, 888 - 893 (2002)
Published online: 21 October 2002 | doi:10.1038/ncb872

NF-kappaB2 p100 is a pro-apoptotic protein with anti-oncogenic function

Yongqing Wang1,4, Hongjuan Cui1,4, Allen Schroering1, Jane L. Ding1, William S. Lane2, Gaël McGill3, David E. Fisher4 & Han-Fei Ding1

Top

Nuclear factor-kappaB (NF-kappaB) promotes cell survival by upregulating expression of anti-apoptotic genes, a process that is antagonized by inhibitors of kappaB (IkappaB) factors1. The only NF-kappaB family member known to be mutated in human cancer is NF-kappaB2 p100 (ref. 2), a factor with IkappaB activity. Here, we report the isolation from irradiated mouse tumour cells of a complex that induces caspase-8 activity in cell-free assays and identify p100 as an essential component of this complex. Expression of p100 profoundly sensitizes cells to death-receptor-mediated apoptosis through a pathway that is independent of IkappaB-like activity. The carboxyl terminus of p100 contains a death domain3 that is absent from all known tumour-derived mutants. This death domain mediates recruitment of p100 into death machinery complexes after ligand stimulation and is essential for p100's pro-apoptotic activity. p100 also sensitizes NIH3T3 cells to apoptosis triggered by oncogenic Ras, resulting in a marked inhibition of transformation that is rescued by suppression of endogenous caspase-8. These observations thus identify an IkappaB-independent apoptotic activity of NF-kappaB2 p100 and help explain its unique tumour suppressor role.

Top
  1. Department of Biochemistry and Molecular Biology, Medical College of Ohio, 3035 Arlington Avenue, Toledo, OH 43614, USA
  2. Harvard Microchemistry and Proteomics Analysis Facility, Harvard University, 16 Divinity Avenue, Cambridge, MA 02138, USA
  3. Department of Pediatric Hematology/Oncology, Dana Farber Cancer Institute and Children's Hospital, 44 Binney Street, Boston, MA 02115, USA
  4. These authors contributed equally to this work.

Correspondence to: David E. Fisher4 e-mail: david_fisher@dfci.harvard.edu

Correspondence to: Han-Fei Ding1 e-mail: hding@mco.edu



MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

RESEARCH
Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes
Oncogene Original Article (10 Mar 2000)
Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
The EMBO Journal Article (01 Nov 1999)
A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins
Nature Immunology Article (01 Jun 2001)


Extra navigation

Subscribe to Nature Cell Biology

Subscribe

Open Innovation Challenges